Biomark Capital

Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies. We target companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health that will change the face of healthcare innovation in the future. We share the drive and vision of our portfolio companies to collaborate with them in accelerating growth and building successful business ventures. Biomark Capital was previously known as GBP Capital.

Biomark Capital, established in 2013 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Health Care, Medical, Wellness, Venture Capital, Finance, Biotechnology, Financial Services, Incubators, Banking, Internet. The organization boasts a portfolio of 14 investments, with an average round size of $25.4M and 7 successful exits. Their recent investments include Spectral Image, WhiteGlove Health, Burrill & Company, WaveTec Vision, DeNovo Ventures. The highest investment round they participated in was $11.5B. Among their most notable exits are Spectral Image and WhiteGlove Health. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.